RT Journal Article
SR Electronic
T1 Genomic epidemiology reveals multiple introductions and spread of SARS-CoV-2 in the Indian state of Karnataka
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.07.10.20150045
DO 10.1101/2020.07.10.20150045
A1 Pattabiraman, Chitra
A1 Habib, Farhat
A1 Harsha, Pk
A1 Rasheed, Risha
A1 Reddy, Vijayalakshmi
A1 Dinesh, Prameela
A1 Damodar, Tina
A1 Hosallimath, Kiran
A1 George, Anson K
A1 Kiran Reddy, Nakka Vijay
A1 John, Banerjee
A1 Pattanaik, Amrita
A1 Kumar, Narendra
A1 Mani, Reeta S
A1 Venkataswamy, Manjunatha M
A1 Shahul Hameed, Shafeeq K
A1 Prakash Kumar, B.G
A1 Desai, Anita
A1 Vasanthapuram, Ravi
YR 2020
UL http://medrxiv.org/content/early/2020/07/24/2020.07.10.20150045.abstract
AB Karnataka, a state in south India, reported its first case of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection on March 8, 2020, more than a month after the first case was reported in India. We used a combination of contact tracing and genomic epidemiology to trace the spread of SARS-CoV-2 in the state up until May 21, 2020 (1578 cases). We obtained 47 full genomes of SARS-CoV-2 which clustered into six lineages (Pangolin lineages—A, B, B.1, B.1.1, B.4, and B.6). The lineages in Karnataka were known to be circulating in China, Southeast Asia, Iran, Europe and other parts of India and are likely to have been imported into the state both by international and domestic travel. Our sequences grouped into 12 contact clusters and 11 cases with no known contacts. We found nine of the 12 contact clusters had a single lineage of the virus, consistent with multiple introductions and most (8/12) were contained within a single district, reflecting local spread. In most of the twelve clusters, the index case (9/12) and spreaders (8/12) were symptomatic. Of the 47 sequences, 31 belonged to the B/B.6 lineage, including seven of eleven cases with no known contact, indicating ongoing transmission of this lineage in the state. Genomic epidemiology of SARS-CoV-2 in Karnataka suggests multiple introductions of the virus followed by local transmission in parallel with ongoing viral evolution. This is the first study from India combining genomic data with epidemiological information emphasizing the need for an integrated approach to outbreak response.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was supported by core funds of NIMHANS to the Department of Neurovirology and the DBT/Wellcome Trust India Alliance Fellowship IA/E/15/1/502336 awarded to Chitra P.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Institutional Ethics Committee (Basic and Neurosciences), National Institute of Mental Health and Neurosciences, BangaloreAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll complete genomes (47) have been deposited in the GISAID database and are publicly available. The line list of cases is available with the State Surveillance Unit, Directorate of Health and Family Welfare, Karnataka https://www.epicov.org/